(Q54084241)

24 May 2018

title

Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure. (English)

1 reference

24 May 2018

0 references

1 reference

1 reference

Hatzizacharias A

1

1 reference

24 May 2018

Makris T

2

1 reference

24 May 2018

Krespi P

3

1 reference

24 May 2018

Triposkiadis F

4

1 reference

24 May 2018

Voyatzi P

5

1 reference

24 May 2018

Dalianis N

6

1 reference

24 May 2018

Kyriakidis M

7

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 August 1999

1 reference

24 May 2018

published in

American Heart Journal

1 reference

24 May 2018

volume

138

1 reference

24 May 2018

issue

2 Pt 1

1 reference

24 May 2018

page(s)

241-246

1 reference

24 May 2018

The epidemiology of heart failure: the Framingham Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Characterization of the Cardiotonic Effects of Milrinone, a New and Potent Cardiac Bipyridine, on Isolated Tissues from Several Animal Species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Use of milrinone in cardiac surgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Milrinone in the treatment of chronic cardiac failure: a controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Short-term use of intravenous milrinone for heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970107-9

10.1016/S0002-8703(99)70107-9

7 January 2021

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

10426834

1 reference

24 May 2018